Literature DB >> 978432

Critical analysis of "flip-flop" phenomenon in two-compartment pharmacokinetic model.

P R Byron, R E Notari.   

Abstract

Computer simulations were used to examine the effect of first-order absorption on the disposition of one- and two-compartment model drugs. Two-compartment systems that attain a clinically acceptable beta-phase after rapid intravenous injection were perturbed by introduction of drug via first-order absorption. The validity of perceiving such a system as a potential "flip-flop" model was tested by comparing the negative slopes of log-linear plasma-time profiles to known values for ka and beta for various values of ka, k12, k21, and k10. Although most log-linear plots showed excellent correlation coefficients (r2 greater than 0.996), their negative slopes (S) did not represent either ka or beta under various combinations. A similar consideration of the one-compartment model enabled a comparison to be made between the two systems. Maximum negative errors were observed for both one- and two-compartment drugs as ka leads to k2 or beta, respectively. The value for S provided a good estimate of the absorption rate constant, ka, when k2 greater than or equal 2ka (one compartment) or beta greater than or equal 2ka. The elimination rate constant (k2 or beta) could be obtained from S for all one-compartment and some two-compartment drugs when the value of ka was approximately twice that of k2 or beta. Large positive errors also were observed with certain two-compartment drugs where the ratio of the four rate constants apparently linearized a nonlinear plasma profile. Conditions wherein S may be expected to approach beta wherein S approaches ka are clearly defined.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 978432     DOI: 10.1002/jps.2600650804

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

Review 1.  Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development.

Authors:  Jaime A Yáñez; Connie M Remsberg; Casey L Sayre; M Laird Forrest; Neal M Davies
Journal:  Ther Deliv       Date:  2011-05

2.  Pharmacokinetics of intravenously and intramuscularly administered cefepime in infants and children.

Authors:  M D Reed; T S Yamashita; C K Knupp; J M Veazey; J L Blumer
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

3.  Coupled solutions of one- and two-compartment pharmacokinetic models with first-order absorption.

Authors:  N Asmanova; G Koloskov; A I Ilin
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-04-10       Impact factor: 2.745

4.  An area function method for estimating the apparent absorption rate constant.

Authors:  H Cheng; A E Staubus; L Shum
Journal:  Pharm Res       Date:  1988-01       Impact factor: 4.200

5.  Generalizations in linear pharmacokinetics using properties of certain classes of residence time distributions. II. Log-concave concentration-time curves following oral administration.

Authors:  M Weiss
Journal:  J Pharmacokinet Biopharm       Date:  1987-02

6.  Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology Group.

Authors:  Wanda L Salzer; Barbara Asselin; Jeffrey G Supko; Meenakshi Devidas; Nicole A Kaiser; Paul Plourde; Naomi J Winick; Gregory H Reaman; Elizabeth Raetz; William L Carroll; Stephen P Hunger
Journal:  Blood       Date:  2013-06-05       Impact factor: 22.113

7.  Peptidoleukotriene (PLT) release and absorption from the airways of the isolated perfused guinea pig lung following chemical and antigenic challenge.

Authors:  R A Kovelesky; P R Byron; J Venitz
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

Review 8.  Modified-Release Formulations of Second-Generation Antiepileptic Drugs: Pharmacokinetic and Clinical Aspects.

Authors:  Gail D Anderson; Russell P Saneto
Journal:  CNS Drugs       Date:  2015-08       Impact factor: 5.749

9.  Pharmacokinetics of ampicillin and its prodrugs bacampicillin and pivampicillin in man.

Authors:  M Ehrnebo; S O Nilsson; L O Boréus
Journal:  J Pharmacokinet Biopharm       Date:  1979-10

10.  Site-differential gastrointestinal absorption of benazepril hydrochloride in healthy volunteers.

Authors:  K K Chan; A Buch; R D Glazer; V A John; W H Barr
Journal:  Pharm Res       Date:  1994-03       Impact factor: 4.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.